![XL184 (Cabozantinib) cuolin-1 [2] TAME accelerates the ATP](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M7865_1619054368.gif?v=1629180221)
Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
[2] TAME accelerates the ATP hydrolysis process about 12-fold
34(6):1482-93
20)7-12/h3
highly potent and selective non-ATP competitive MEK inhibitor
Formula: C25H27F4N3O3S
XL184 (Cabozantinib) cuolin-1 [2] TAME accelerates the ATPCabozantinib, also known as XL 184 or BMS 907351, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several tyrosine receptor kinases. Specifically, cabozantinib appears to have a strong affinity for the hepatocyte growth factor receptor (Met) and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in inhibition of
US$ 670.00
US$ 16.00